Where does Umoja Biopharma's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Umoja Biopharma's 1 recorded funding rounds.

Premier Alternatives

Umoja Biopharma

Seattle, WA · Founded 2019 · Privately Held (backing)

Operator of a biotechnology platform designed to advance a novel approach to cancer immunotherapy by generating engineered immune cells. Umoja Biopharma is based in Seattle, WA and was founded in 2019. It is valued at about $509 million as of Oct 2026, set by institutional fund marks, up 21% since its later-stage round in Jan 2025. It has raised $371 million across 1 recorded round; the latest was a $210 million later-stage round in Jun 2021.

PMV mark · valuation

$508.8M

Oct 2026

Since last round

+21%

Jan 2025

Total raised

$371.0M

Last round

Later Stage VC

Jun 2021

Cap table — not yet on record

Umoja Biopharma's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Pro

The prices on Umoja Biopharma

·6 fund marks: filer, period, implied $/share

Pro · $99 a month

List $299 · founding price, locked for as long as you stay

Membership and data by Private Market View

Or create a free account

Frequently asked about Umoja Biopharma

Where does Umoja Biopharma's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Umoja Biopharma's 1 recorded funding rounds.